Instituto de Investigación Sanitaria Biobizkaia-ko ikertzaileekin lankidetzan egindako argitalpenak (32)

2024

  1. A 20-year overview of fertility preservation in boys: new insights gained through a comprehensive international survey

    Human Reproduction Open, Vol. 2024, Núm. 2

  2. Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)

    Cytotherapy, Vol. 26, Núm. 1, pp. 25-35

2023

  1. Analysis of the impact of handling and culture on the expansion and functionality of NK cells

    Frontiers in Immunology, Vol. 14

  2. Application of new technologies in embryos: From gene editing to synthetic embryos

    Human Reproductive and Prenatal Genetics (Elsevier), pp. 853-886

  3. Cell-cell interactions during the formation of primordial follicles in humans

    Life science alliance, Vol. 6, Núm. 11

  4. Natural killer cell subsets in endometrial fluid: a pilot study of their association with the endometrial cycle and reproductive parameters

    Journal of Assisted Reproduction and Genetics, Vol. 40, Núm. 9, pp. 2241-2250

  5. Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model

    Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 6

  6. Rationale for combined therapies in severe-to-critical COVID-19 patients

    Frontiers in Immunology, Vol. 14

  7. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)

    Bone Marrow Transplantation

  8. Towards tailored surface topography on electrospun wound dressings for exudate absorption

    Surface Innovations, Vol. 12, Núm. 3-4, pp. 252-264

2022

  1. A Comparative Study of Cell Culture Conditions during Conversion from Primed to Naive Human Pluripotent Stem Cells

    Biomedicines, Vol. 10, Núm. 6

  2. Identifying SARS-CoV-2 ‘memory’ NK cells from COVID-19 convalescent donors for adoptive cell therapy

    Immunology, Vol. 165, Núm. 2, pp. 234-249

  3. Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics

    NMR in Biomedicine, Vol. 35, Núm. 2

2021

  1. A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

    Trials, Vol. 22, Núm. 1

  2. Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing (Stem Cell Research & Therapy, (2020), 11, 1, (453), 10.1186/s13287-020-01964-5)

    Stem Cell Research and Therapy

  3. Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells

    Stem Cell Research and Therapy, Vol. 12, Núm. 1

  4. Improving in vitro culture of human male fetal germ cells

    Cells, Vol. 10, Núm. 8

  5. Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

    EClinicalMedicine, Vol. 39

  6. SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and Large-Scale Production for Adoptive Cell Therapy

    Frontiers in Cell and Developmental Biology, Vol. 9

  7. The race of CAR therapies: CAR-NK cells for fighting B-cell hematological cancers

    Cancers, Vol. 13, Núm. 21